ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

218 filings reported holding SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q2 2025.
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) has 185 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 84,521,210 shares of 98,567,360 outstanding shares and own 85.75% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10,860,977 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (9,724,508 shares), ORBIMED ADVISORS LLC (8,288,510 shares), BlackRock, Inc. (4,423,464 shares), SR One Capital Management, LP (4,012,903 shares), ALLIANCEBERNSTEIN L.P. (3,825,793 shares), VANGUARD GROUP INC (3,262,673 shares), CITADEL ADVISORS LLC (2,242,176 shares), STATE STREET CORP (2,194,493 shares), and FRANKLIN RESOURCES INC (1,828,755 shares).
This table shows the top 185 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.